Skip to content

CSN3 promotes colorectal cancer cell progression through activation of the PI3K/AKT/mTOR pathway

Oct 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 18 references
Medicine

TL;DR

CSN3 promotes malignant CRC cell phenotypes partly through AKT signaling, with CSN1S1 contributing to CSN3-mediated AKT activation and tumor-promoting effects, suggesting potential prognostic relevance in CRC.

View source

Similar papers

Open access Sep 2026

P4HA3 promotes gastric cancer cell proliferation and invasion via the PI3K/AKT/mTOR signaling pathway and regulates glycolytic metabolic reprogramming.

Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.

Tao Wang, Xiao Xu, C. Jin et al. · 0 citations
Sep 2026

CircARHGAP10 inhibits colorectal cancer cell proliferation, migration and invasion by governing the miR-29a-5p/LPP axis and regulating Wnt/β-catenin signaling pathway

It is revealed that circARHGAP10 functions as a tumor suppressor in CRC via two independent regulatory branches downstream of the circARHGAP10/miR-29a-5p cascade, and this newly identified circRNA-centered regulatory network provides a promising novel therapeutic target for CRC intervention.

Li-Yuan Liu, Yong-Cun Jia, Dong-Jie Li et al. · 0 citations
Open access Sep 2026

Transcription factor KLF4 suppresses the malignant progression of colorectal cancer by activating ETFDH transcription.

Colorectal cancer (CRC) is a common cause of cancer-related deaths worldwide. Electron transfer flavoprotein dehydrogenase (ETFDH) is a novel prognostic biomarker for human CRC. However, the role and molecular mechanism of ETFDH in CRC are still unclear. DEGs in CRC development were identified using mRNA microarray dat...

Yan Zeng, Qiao-Zhen Liu, Ya-Li Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.